Drug
City Rbp4
City Rbp4: highest development phase Phase 1, developed by City Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- City Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CITY-RBP4 NCT07836452 | Phase 1 | Stargardt Disease 1 |
Latest
No recent events.
Follow City Rbp4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.